This Section is designed for healthcare professionals and GP Practice staff.

For public information, please visit the Brighton and Hove CCG public home page.

Joint Formulary

The Joint Formulary

  We are currently reviewing the Brighton Joint Formulary platform.  Please fill in this short survey which will influence any future developments.  https://www.surveymonkey.co.uk/r/F82HSMJ 

 

The Brighton and Hove and High Weald Lewes Haven Joint Formulary is a list of everything which can be prescribed.

The Joint Formulary is overseen by the Brighton Area Prescribing Committee, and is developed and maintained with the collaboration of the following organisations:

Patients and public

If you are a patient or member of the public and would like information about the Joint Formulary, please get in touch using the details below.

Patients registered with a Brighton and Hove practice
Email: BHCCG.MedicinesManagement@nhs.net

Patients registered with a High Weald Lewes Havens practice
Email: hwlhccg.mmt@nhs.net

How to use the Joint Formulary

The Joint Formulary is broken down into chapters, based upon the categories used in the British National Formulary (BNF). It comprises a list of drugs recommended in each section. Each drug is colour-coded in a traffic-light system to facilitate prescribing choice. For more details on the Joint Formulary traffic light system, please see the drop down list below below.

The prescriber should always ensure they have the expertise to prescribe an agent before making a selection. In its guidelines on responsibility for prescribing between hospitals and general practitioners, the Department of Health has advised that legal responsibility for prescribing lies with the doctor who signs the prescription.

If you wish to make a formulary application to the Brighton Area Prescribing Committee, please contact the Brighton & Hove Medicines Management Team.

Please follow the link for Palliative Care for local and national guidance including the support folder and drug instruction chart.  

All medicines listed in the palliative care folder are available for GP prescribing and can be found in their respective BNF categories in the Joint Formulary.

Supporting Information for the Joint Formulary

Please see the Supporting Information on the Joint Formulary or click on the below links for information on:

Introduction Joint Formulary Traffic Light System

Green - Non-Specialist Drugs

Suitable for non-specialist initiation.

Blue - Specialist Initiation WITHOUT Shared Care Guidelines

For drugs that do not require specific monitoring or where the monitoring is on-going by the specialist. The drugs are recommended or initiated by a specialist and GPs continue to prescribe on specialist advice without the need for a formal shared care guideline but a shared care information sheet setting out responsibilities may be available. A minimum of one month's supply of medication will be provided by the consultant if initiating. Information on the initiation process and whether a shared care information sheet will be supplied will be detailed on the Joint Formulary.

Amber - Specialist Initiation WITH Shared Care Guidelines

For drugs which require specialist initiation and/or dose titration and specific ongoing monitoring. For initiation, dose stabilisation and prescribing (including monitoring) by a specialist until the patient is stabilised (usually for a minimum 3 months but see individual shared care protocols) after which the GP can be asked to agree shared care through the use of shared care guidelines. Primary care will be expected to undertake some specific monitoring under shared care.

Red - Specialist ONLY drugs

For initiation and continuation (including monitoring) by a specialist only. A specialist is not necessarily a consultant, rather a practitioner with specialist skills e.g. specialist registrar, nurse specialist, GP with specialist interest, community psychiatric nurse, tissue viability nurse.

Black - Not routinely supported

Drugs that have been considered by the APC and are not routinely supported for initiation in any health setting for NHS patients.

Non-Formulary - Drugs which do not appear in the Joint Formulary

Any drugs not listed in this formulary have NOT been considered by the Area Prescribing Committee and therefore are NOT routinely supported for initiation in any health setting for NHS patients.

Appendix 1 Borderline Substances

Appendix 1 of the Joint Formulary is for use by prescribers.

If you have any questions about this document, please contact the Medicines Management Team.

Appendix 2 Stoma Care Accessories

Appendix 2 of the Joint Formulary is for use by prescribers.

If you have any questions about this document, please contact the Medicines Management Team.

Appendix 3 Blacklist Drugs not routinely supported

Appendix 3 of the Joint Formulary is for use by prescribers.

If you have any questions about this document, please contact the Medicines Management Team.

Appendix 4 Wound Management Products and Elasticated Garments

The Wound Management Products and Elasticated Garments formulary is for use by:

  • practice nurses
  • community nurses
  • nursing homes
  • tissue viability nurses

If you have any questions about this document, please contact the Medicines Management Team.

Appendix 5 Continence

Appendix 5 of the Joint Formulary is for use by prescribers.

If you have any questions about this document, please contact the Medicines Management Team.

Chapter 1 Gastrointestinal

Chapter 1 of the Joint Formulary is for use by prescribers.

If you have any questions about this document, please contact the Medicines Management Team.

Chapter 2 Cardiovascular

Chapter 2 of the Joint Formulary is for use by prescribers.

If you have any questions about this document, please contact the Medicines Management Team.

Chapter 3 Respiratory

Chapter 3 of the Joint Formulary is for use by prescribers.

If you have any questions about this document, please contact the Medicines Management Team.

Chapter 4 Central Nervous System

Chapter 4 of the Joint Formulary is for use by prescribers.

If you have any questions about this document, please contact the Medicines Management Team.

Chapter 5 Infections

Chapter 5 of the Joint Formulary is for use by prescribers.

If you have any questions about this document, please contact the Medicines Management Team.

Chapter 6 Endocrine

Chapter 6 of the Joint Formulary is for use by prescribers.

If you have any questions about this document, please contact the Medicines Management Team.

Please see Clinical Prescribing Documents and Resources - Endocrine for Formulary Blood Glucose Monitors and Test Strips

Chapter 7 Gynaecological and Urinary Tract

Chapter 7 of the Joint Formulary is for use by prescribers.

If you have any questions about this document, please contact the Medicines Management Team.

Chapter 8 Malignant Disease and Immunosuppression

Chapter 8 of the Joint Formulary is for use by prescribers.

If you have any questions about this document, please contact the Medicines Management Team.

Chapter 9 Nutrition and Blood

Chapter 9 of the Joint Formulary is for use by prescribers.

If you have any questions about this document, please contact the Medicines Management Team.

Chapter 10 Musculoskeletal

Chapter 10 of the Joint Formulary is for use by prescribers.

If you have any questions about this document, please contact the Medicines Management Team.

Chapter 11 Eye

Chapter 11 of the Joint Formulary is for use by prescribers.

If you have any questions about this document, please contact the Medicines Management Team.

Chapter 12 Ear, Nose and Throat (ENT)

Chapter 12 of the Joint Formulary is for use by prescribers.

If you have any questions about this document, please contact the Medicines Management Team.

Chapter 13 Skin

Chapter 13 of the Joint Formulary is for use by prescribers.

If you have any questions about this document, please contact the Medicines Management Team.

Chapter 14 Immunological Products and Vaccines

Chapter 14 of the Joint Formulary is for use by prescribers.

If you have any questions about this document, please contact the Medicines Management Team.

Chapter 15 Anaesthesia

Chapter 15 of the Joint Formulary is for use by prescribers.

If you have any questions about this document, please contact the Medicines Management Team.